169 related articles for article (PubMed ID: 31100200)
1. Influence of E-cadherin genetic variation in canine mammary tumour risk, clinicopathological features and prognosis.
Canadas A; Santos M; Medeiros R; Dias-Pereira P
Vet Comp Oncol; 2019 Dec; 17(4):489-496. PubMed ID: 31100200
[TBL] [Abstract][Full Text] [Related]
2. Single Nucleotide Polymorphisms Influence Histological Type and Grade of Canine Malignant Mammary Tumours.
Canadas-Sousa A; Santos M; Medeiros R; Dias-Pereira P
J Comp Pathol; 2019 Oct; 172():72-79. PubMed ID: 31690419
[TBL] [Abstract][Full Text] [Related]
3. Catechol-o-methyltransferase genotypes are associated with progression and biological behaviour of canine mammary tumours.
Canadas A; Santos M; Pinto R; Medeiros R; Dias-Pereira P
Vet Comp Oncol; 2018 Dec; 16(4):664-669. PubMed ID: 30168237
[TBL] [Abstract][Full Text] [Related]
4. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
[TBL] [Abstract][Full Text] [Related]
5. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptors genotypes and canine mammary neoplasia.
Canadas-Sousa A; Santos M; Leal B; Medeiros R; Dias-Pereira P
BMC Vet Res; 2019 Sep; 15(1):325. PubMed ID: 31506083
[TBL] [Abstract][Full Text] [Related]
7. Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors.
Dias Pereira P; Lopes CC; Matos AJ; Pinto D; Gärtner F; Lopes C; Medeiros R
Vet Pathol; 2008 Mar; 45(2):124-30. PubMed ID: 18424824
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours.
Enginler SO; Akış I; Toydemir TS; Oztabak K; Haktanir D; Gündüz MC; Kırşan I; Fırat I
Vet Res Commun; 2014 Mar; 38(1):21-7. PubMed ID: 24122022
[TBL] [Abstract][Full Text] [Related]
9. Canine mammary tumor risk is associated with polymorphisms in RAD51 and STK11 genes.
Canadas A; Santos M; Nogueira A; Assis J; Gomes M; Lemos C; Medeiros R; Dias-Pereira P
J Vet Diagn Invest; 2018 Sep; 30(5):733-738. PubMed ID: 30027822
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.
Reis AL; Carvalheira J; Schmitt FC; Gärtner F
Vet Rec; 2003 May; 152(20):621-4. PubMed ID: 12790166
[TBL] [Abstract][Full Text] [Related]
11. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of genome-wide structural aberrations in canine mammary tumours using single nucleotide polymorphism (SNP) genotyping assay.
Surdyka M; Gurgul A; Slaska B; Pawlina K; Szmatola T; Bugno-Poniewierska M; Smiech A; Kasperek K
Pol J Vet Sci; 2019 Mar; 22(1):133-141. PubMed ID: 30997777
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression in canine mammary carcinomas with regional lymph node metastases.
Brunetti B; Sarli G; Preziosi R; Leprotti S; Benazzi C
J Vet Med A Physiol Pathol Clin Med; 2003 Dec; 50(10):496-500. PubMed ID: 15157016
[TBL] [Abstract][Full Text] [Related]
14. α-catenin, β-catenin and P-120-catenin immunoexpression in canine mammary tissues and their relationship with E-cadherin.
da Rocha AA; Carvalheira J; Gärtner F
Res Vet Sci; 2020 Jun; 130():197-202. PubMed ID: 32200159
[TBL] [Abstract][Full Text] [Related]
15. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
17. Influence of catechol-O-methyltransferase (COMT) genotypes on the prognosis of canine mammary tumors.
Dias Pereira P; Lopes CC; Matos AJ; Pinto D; Gärtner F; Lopes C; Medeiros R
Vet Pathol; 2009 Nov; 46(6):1270-4. PubMed ID: 19605895
[TBL] [Abstract][Full Text] [Related]
18. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
19. Identification of genetic variation in 11 candidate genes of canine mammary tumour.
Borge KS; Børresen-Dale AL; Lingaas F
Vet Comp Oncol; 2011 Dec; 9(4):241-50. PubMed ID: 22077404
[TBL] [Abstract][Full Text] [Related]
20. Co-localization of PTEN and E-cadherin in canine mammary hyperplasias and benign and malignant mammary tumors.
Asproni P; Ressel L; Millanta F; Vannozzi I; Poli A
Res Vet Sci; 2015 Dec; 103():113-8. PubMed ID: 26679805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
